Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Febit Establishes US Company

Published: Tuesday, August 15, 2006
Last Updated: Tuesday, August 15, 2006
Bookmark and Share
Febit launches the GENIOM biochip system in the US.

febit biotech gmbh has announced the establishment of febit Incorporation, a Delaware Company based in Medford, Boston/USA.

febit Inc. will be supporting all operations throughout America: in the US, Canada and the Southern American countries. With its presence in the Unites States, febit enters the largest market for biochip technology worldwide.

Thus, GENIOM sales and customer support will be handled by qualified stuff on site. All team members are experienced in the US market.

The knowledge transfer required for a start of febit Inc. was achieved by several months of prior training for technical specialists and the US management.

Temporary delegation of febit biotech gmbh staff is envisaged as well. A fully equipped application laboratory is already established that will enable customers to perform hands-on tests of their applications on the GENIOM system and develop assays in cooperation with febit Inc.

In addition, febit will offer workshops featuring various GENIOM applications. Production for the Americas (Northern and Southern America) is expected to take place in close cooperation with US-based companies.

febit Inc. is directed by Claus E. Schmidt, Vice President Operations & General Manager, an entrepreneur experienced in knowledge transfer between Europe and the USA.

In addition, he contributes expertise in the field of chemical engineering. febit Inc. CEO Cord F. Stahler directs febit biotech gmbh in Heidelberg as well and is an accomplished manager in the international biomedical technology business.

The Operative Management is completed by Stefan M. Matysiak, PhD, Director Customer Care, who is primarily responsible for customer care and the applications laboratory.

He has several years of experience in research and development, working for renowned companies and institutions in the US and Germany, such as Applied Biosystems Inc. and the German Cancer Research Center.

The Supervisory Board of febit Inc. - as the one of febit biotech gmbh - is chaired by Dr. Gerald Moller, Director of HBM BioCapital Management GmbH and former president and CEO of the Boehringer Mannheim Group.

Vice Chairman of the Supervisory Board is Michael Kranich, Director of DH-Capital GmbH & Co. KG and OH-Beteiligungen GmbH & Co. KG that holds the majority of febit biotech GmbH for the Hopp family.

Dietmar Hopp, co-founder of SAP and its CEO and Chairman for many years, is the most potent single investor of the German biotech industry.

He primarily invests in young, promising companies in that business such as febit biotech gmbh. Supporting febit´s establishment on the American continent, he expands his engagement in the fastest-growing biotech market.

Establishing a US-based company is a logical step for Cord F. Stahler, CEO of febit Inc, "After a successful start of GENIOM in the European market, penetration of the US as the largest biochip market is an essential move in our marketing strategy."

"We are confident that our US customers as well will be convinced by the unique speed and flexibility of our system in microarray synthesis and analysis."

"With a highly efficient team in the country, we are able to specifically address this market and successfully expand our business there."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Decoding the RNA Operating System of the Cell with Up-to-date miRNA Profiling Service
According to febit, its new microRNA profiling services can make researchers stay ahead in microRNA research.
Tuesday, September 11, 2007
Geniom Technology Applied to Targeted Next-Generation Sequencing
By enabling selective targeting, the Geniom® Biochip will allow researchers to sequence individual and well defined parts of genomes
Tuesday, July 24, 2007
Febit Achieves Sales Goals
Febit successfully markets the GENIOM bioanalysis device.
Thursday, March 16, 2006
Scientific News
Discovery Provides New Opportunities for Chips
Scientists at the University of Twente's MESA+ research institute have developed a new manufacturing method to create three-dimensional nanostructures.
Penn Engineering Team Showcases ‘Eye-on-a-Chip’ Technology
These small plastic chips contain microfluidic channels, carefully designed so that human cells can grow in them in a way that simulates the three-dimensional environments they would normally inhabit in the body.
Miniaturizable Magnetic Resonance
Microscopic gem the key to new development in magnetic lab-on-a-chip technology.
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Chip-Based Technology Enables Reliable Direct Detection of Ebola Virus
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA.
Stem Cell Research Hints at Evolution of Human Brain
Researchers at UC San Francisco have succeeded in mapping the genetic signature of a unique group of stem cells in the human brain that seem to generate most of the neurons in our massive cerebral cortex.
Developing a Breathalyzer-Type Low Blood Sugar Warning Device For Diabetes
A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.
Smartphone App to Monitor Serious Blood Disorder
A researcher from Florida Atlantic University has come up with a unique way to monitor sickle cell disease -- a serious blood disorder -- using a smart phone.
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.
‘Lab-on-a-Chip’ Technology Cuts Costs of Lab Tests
With ability to analyze minuscule amounts of fluid, Rutgers breakthrough could also promote central nervous system and joint research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos